GSA Capital Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

GSA Capital Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,096	Closed	-$304K	–	1886
2019 Q3	$304K	Sell	16,096 -2,585	-14%	-$29.6K	0.04%	884
2019 Q2	$220K	Buy	18,681 +7,283	+64%	+$88.2K	0.02%	1191
2019 Q1	$156K	Buy	+11,398	New	+$148K	0.02%	1282
2015 Q4	–	Sell	-8,622	Closed	-$282K	–	2055
2015 Q3	$282K	Buy	8,622 +2,922	+51%	+$124K	0.01%	1401
2015 Q2	$302K	Sell	5,700 -1,580	-22%	-$57.5K	0.01%	1611
2015 Q1	$210K	Buy	+7,280	New	+$200K	0.01%	1907

GSA Capital Partners's ALDR Position: Q4 2019 in Review

GSA Capital Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 16,096 shares — an estimated $304K sold.

GSA Capital Partners first reported a position in ALDR in Q1 2015 and held it in 6 quarters. The position peaked at $304K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

GSA Capital Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
GSA Capital Partners sold 16,096 Alder Biopharmaceuticals shares in Q4 2019, an estimated $304K.
GSA Capital Partners first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 6 quarters.
GSA Capital Partners's Alder Biopharmaceuticals position peaked at $304K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on GSA Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.